All lobbying filings

RK STRATEGIES, INC.

RK STRATEGIES, INC. filed a Q3 report for RECCE PHARMACEUTICALS LTD on October 20, 2025, reporting $20,000 in lobbying income.

Lobbying for RECCE PHARMACEUTICALS LTD · Pharmaceutical Company - Anti-infectives

All filings by RK STRATEGIES, INC. · Everything RECCE PHARMACEUTICALS LTD has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Income

$20,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

General healthcare/wound care issues

General biodefense/wound care issues

General wound care issues

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem